Antibody-drug conjugate shows efficacy against cell surface protein in neuroblastoma
(Children's Hospital of Philadelphia) Physician-scientists in the Cancer Center at Children's Hospital of Philadelphia have developed a preclinical, potent therapy attached to an antibody that targets a surface protein expressed in most childhood neuroblastomas, effectively killing cancer cells.
Source: EurekAlert! - Biology - Category: Biology Source Type: news
More News: Biology | Brain | Cancer | Cancer & Oncology | Childhood Cancer | Children | Hospitals | Neuroblastoma | Neurology